Hospira recalls one lot of electrolyte solution; Lilly wants to keep its animal health biz;

@FiercePharma: Another Hospira recall: Electrolyte solution, after customer complained of mold. No reported injuries. More | Follow @FiercePharma

 @AlisonBFierce: DARPA produced 10 million H1N1 flu vaccine doses in a month. DARPA, Medicago are using tobacco plants instead of eggs. News | Follow @AlisonBFierce

@EricPFierce: Sartorius Stedim nabs top LEED designation for Puerto Rico plant that recycles AC condensation, uses solar power. Article | Follow @EricPFierce

> In another recall from Hospira ($HSP), the company pulled one lot of electrolyte solution after a customer complained of mold in the packaging; FDA said no injuries have been reported. Report

> Eli Lilly ($LLY) has no interest in unloading its animal-health unit Elanco, a la Pfizer's ($PFE) spinoff of Zoetis, CFO Derica Rice said. Report

> Sanofi's ($SNY) animal health unit Merial was sued in a patent challenge to its Frontline flea and tick products. Report

> India's Glenmark Pharmaceuticals posted a 5-fold hike in net profits for its fiscal third quarter, thanks to a 30% growth in sales. Report

> Novartis' ($NVS) eye care division Alcon is investing $250 million in its Ciba Vision manufacturing operations in Georgia. Report

Medical Device News

 @FierceMedDev: Medtronic launches large-scale neurostimulation trial. Item | Follow @FierceMedDev

 @MarkHFierce: BSX will cut as many as 1,000 additional jobs beyond 2011 restructuring--first disclosed in today's Q4 announcement. Release | Follow @MarkHFierce

 @DamianFierce: Next in the Bausch + Lomb saga: Either it's going for an IPO or this is a gambit to pressure buyers. News | Follow @DamianFierce

> Illumina soars on deCode sale, revenue jump. Report

> Blood Dx quickens search for breast cancer mutations. Story

Biotech News

 @FierceBiotech: Genentech plucks rights to Afraxis drug assets in $187M deal. News | Follow @FierceBiotech

@JohnCFierce: Big Biotech throwing up state legislative roadblocks against biosimilars, from Pollack at the NYT. More | Follow @JohnCFierce

@RyanMFierce: Biotech billionaire Soon-Shiong unveils 'convergence' cancer drug startup... Why it's unique? Tech convergence. News | Follow @RyanMFierce

> Pfizer on track to chop R&D budget back to $6.5B-$7B range. Story

> Bristol-Myers dumps rights to Lilly's troubled PhIII Erbitux successor. News

> Amgen, Genentech push blockbuster protection bills in states. Article

Pharma Manufacturing News

> Hospira recalls product that may contain mold. News

> EU drugmakers say expect a year from OK to warehouse for new labels. Item

> FDA alleges 3 made millions off scam wholesaler. Story

> Sartorius PR plant first to get LEED's top rating. Article

Biotech Research News

> Addex approaches the clinic for rare dystonias. Article

> Orexo, AstraZeneca join forces against respiratory disease. Item

> Beta blockers could improve cancer treatment in stressed patients. News

> Stem cells help rats recover from stroke. Story

And Finally... Adult migraine remedies don't prevent the headaches in children, a JAMA Pediatrics analysis found. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.